Medicalia.org

by Internet Medical Society

The FDA approved the drug Ibrutinib for treating the patients with Waldenström's macroglobulinemia, mantle cell lymphoma, chronic lymphocytic leukemia, and chronic lymphocytic leukemia (CLL) with 17p deletion. The active ingredient in the medicine is Ibrutinib, along with inactive ingredients croscarmellose sodium, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate. The drug Ibrutinib is a tyrosine kinase inhibitor that comes in the form of 140 mg capsules for oral administration. One should swallow the capsules whole, do not break, chew or crush the capsule.

Ibrutinib capsules 140 mg price in India is affordable, and one can purchase this medicine from multiple suppliers of generic medications. For further information, reach us on 18008891064.

Views: 4

Reply to This

Advertisement

Interested in advertising on Medicalia.org?

-------------------------

-------------------------

-------------------------

INTERNATIONAL ARCHIVES OF MEDICINE

Submit your manuscript

© 2022   Created by Network Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service